-
1
-
2
A systematic review of the cost-effectiveness of anti-VEGF drugs for the treatment of diabetic retinopathy
Published 2025-01-01Subjects: Get full text
Article -
3
Pooled Multicenter Safety Analysis of Lupin’s Intravitreal Biosimilar Ranibizumab (Ranieyes) in Chorioretinal Vascular Diseases
Published 2024-11-01Subjects: “…Ranibizumab…”
Get full text
Article -
4
Comparison of reactivation between ranibizumab and bevacizumab in aggressive retinopathy of prematurity: A retrospective case series
Published 2025-01-01Subjects: Get full text
Article -
5
Innovator ranibizumab ComparEd to Biosimilar ranibizumab in combination with Expansile gas in submaculaR HemorrhaGe: the ICEBERG study
Published 2025-01-01Subjects: Get full text
Article -
6
THE ROLE OF ANTI-VEGF THERAPY IN IMPROVING THE EFFICACY OF SURGICAL TREATMENT OF SECONDARY NEOVASCULAR GLAUCOMA
Published 2024-10-01Subjects: Get full text
Article